(Q39740458)

14 September 2017

Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol (English)

1 reference

14 September 2017

1 reference

1 reference

Scott Walsh

1

1 reference

14 September 2017

Anjali Shah

series ordinal

2

1 reference

14 September 2017

James Mond

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

47

1 reference

14 September 2017

2

1 reference

14 September 2017

554-558

1 reference

Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151727

Peptide and protein PEGylation: a review of problems and solutions

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151727

Synthesis and characterization of poly(ethylene glycol)-insulin conjugates

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151727

Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151727

Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151727

Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151727

Lysostaphin: model for a specific enzymatic approach to infectious disease.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151727

Antigenic response to topically applied proteins

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151727

Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151727

Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine).

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151727

Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRN8601) in the rat

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151727

Polyethylene glycol-modified concanavalin A as an effective agent to stimulate anti-tumor cytotoxicity

15 June 2018

1 reference

12 December 2020

The fate of interleukin-2 after in vivo administration

1 reference

12 December 2020

Enhanced antitumor potency of polyethylene glycolylated tumor necrosis factor-alpha: a novel polymer-conjugation technique with a reversible amino-protective reagent

1 reference

12 December 2020

B-Domain deleted recombinant coagulation factor VIII modified with monomethoxy polyethylene glycol

1 reference

12 December 2020

10.1128/AAC.47.2.554-558.2003

Identifiers

DOI

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

12543658

1 reference